Literature DB >> 8196298

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis.

T Yamamoto1, N A Noble, D E Miller, W A Border.   

Abstract

We found that TGF-beta 1 expression and increased matrix production is transient and self-limited in nephritic glomeruli from rats with acute, reversible glomerulonephritis induced by a single injection of an antibody reactive with glomerular mesangial cells. In contrast, in rats given a second antibody injection, one week later, the glomerular expression of TGF-beta 1 mRNA and TGF-beta 1 protein remained elevated through 18 weeks and was associated with a large infiltration of mononuclear cells, with staining features of fibroblastic/myofibroblastic cells, strongly expressing TGF-beta 1 in the tubulointerstitium of the kidney. By 18 weeks kidneys from animals receiving two antibody injections showed glomerulosclerosis and tubulointerstitial fibrosis with striking deposition of collagens type I and III, whereas kidney tissue from animals given one antibody injection was indistinguishable from normal control. The histological changes were accompanied by persistent proteinuria and elevated levels of blood urea nitrogen. Extracellular matrix markers of TGF-beta 1 activity, a special isoform of fibronectin, tenascin, biglycan and plasminogen activator inhibitor-1, were significantly elevated in kidneys undergoing fibrosis. These data suggest that sustained TGF-beta 1 expression contributes to the development of progressive kidney fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196298     DOI: 10.1038/ki.1994.122

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  83 in total

1.  Unexpected news in renal fibrosis.

Authors:  Juan A Oliver
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Kindlin-2 Association with Rho GDP-Dissociation Inhibitor α Suppresses Rac1 Activation and Podocyte Injury.

Authors:  Ying Sun; Chen Guo; Ping Ma; Yumei Lai; Fan Yang; Jun Cai; Zhehao Cheng; Kuo Zhang; Zhongzhen Liu; Yeteng Tian; Yue Sheng; Ruijun Tian; Yi Deng; Guozhi Xiao; Chuanyue Wu
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

3.  The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.

Authors:  M Takada; A Chandraker; K C Nadeau; M H Sayegh; N L Tilney
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1.

Authors:  Shenaz Khan; Sujata Lakhe-Reddy; Joseph H McCarty; Christine M Sorenson; Nader Sheibani; Louis F Reichardt; Jane H Kim; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 5.  Biomarkers for incident CKD: a new framework for interpreting the literature.

Authors:  Michael G Shlipak; Erica C Day
Journal:  Nat Rev Nephrol       Date:  2013-06-11       Impact factor: 28.314

Review 6.  Reshaping the interstitium by platelet-derived growth factor. Implications for progressive renal disease.

Authors:  K A Nath
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis.

Authors:  W W Tang; T R Ulich; D L Lacey; D C Hill; M Qi; S A Kaufman; G Y Van; J E Tarpley; J S Yee
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage.

Authors:  Vijay Saxena; Douglas W Lienesch; Min Zhou; Ramireddy Bommireddy; Mohamad Azhar; Thomas Doetschman; Ram Raj Singh
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

9.  Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.

Authors:  Aleksandra Krupa; Robert Jenkins; Dong Dong Luo; Aled Lewis; Aled Phillips; Donald Fraser
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

Review 10.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.